Show Notes
Linder B et al., Cell - This episode explores a pan-epitranscriptomic mechanism showing how m6A in coding sequences slows ribosomal decoding to trigger translation-dependent mRNA decay, and how the tRNA wobble modification mcm5s2U counteracts that effect to tune decay and impact oncogenic pathways. Key terms: m6A, tRNA modification, mcm5s2U, mRNA decay, ribosome profiling.
Study Highlights:
The authors show that m6A located in coding sequences deoptimizes specific codons, increasing ribosome A-site occupancy and inducing collisions that couple translation to mRNA decay. Ribosome profiling and inhibition of METTL3 confirm that m6A-modified codons are decoded less efficiently in vivo. The tRNA anticodon modification mcm5s2U alleviates m6A-induced pausing at specific codons, and loss of mcm5s2U strengthens pauses and accelerates decay. The mcm5s2U/m6A balance tunes decay of functionally related mRNA regulons, including oncogenic signaling pathways, and correlates with tumor aggressiveness.
Conclusion:
m6A in the CDS marks transcripts for translation-dependent decay by impairing codon decoding, while the tRNA mcm5s2U modification rescues decoding efficiency and thereby tunes mRNA stability; the interplay has implications for cancer biology and biomarker development.
Music:
Enjoy the music based on this article at the end of the episode.
Article title:
tRNA modifications tune m6A-dependent mRNA decay
First author:
Linder B
Journal:
Cell
DOI:
10.1016/j.cell.2025.04.013
Reference:
Linder B., Sharma P., Wu J., et al. tRNA modifications tune m6A-dependent mRNA decay. Cell. 2025;188:3715–3727. doi:10.1016/j.cell.2025.04.013
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:
❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01
☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
More at basebybase.com
On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/decoding-zuf-yntmk-tz
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-06-14.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript’s core mechanistic narrative: location-dependent m6A effects in CDS vs 3′UTR, ribosome pausing and collisions, the mcm5s2U tRNA wobble modification, codon-specific decoding (GGA vs AGA/GAA), CRISPR KO experiments (ELP1/CTU2), METTL3 inhibition (STM2457), and cancer-associated implications.
- transcript topics: Location-dependent m6A effects in CDS versus 3′UTR and decay; Ribosome pausing and collisions linked to m6A; mcm5s2U tRNA modification and decoding at wobble position; Codon-specific decoding effects (GGA vs AGA/GAA); CRISPR knockouts ELP1 and CTU2 and their impact on decoding; METTL3 inhibition with STM2457 and m6A deposition
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 6
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- m6A in the CDS triggers rapid mRNA turnover (CDS-positioning of m6A drives decay).
- m6A-modified codons show higher ribosome A-site occupancy, indicating slower decoding; codon-identity modulates the effect (GGA strong; AGA/GAA weaker).
- mcm5s2U in tRNA modulates decoding of m6A-modified codons, counteracting the m6A-induced slowdown (acts as a 'shock absorber').
- KO of mcm5s2U biogenesis factors (ELP1, CTU2) removes the compensatory modification, enhancing pausing/collisions at m6A-modified codons and accelerating decay.
- STM2457 (METTL3 inhibitor) reduces m6A deposition and stabilizes CDS-decay transcripts, linking the decay to METTL3 activity.
- m6A/mcm5s2U balance influences oncogenic signaling transcripts and correlates with tumor aggressiveness/prognosis; potential pan-cancer biomarker.
QC result: Pass.
